1

NuVasive

#3607

Rank

$2.19B

Marketcap

US United States

Country

NuVasive
Leadership team

Mr. J. Christopher Barry (CEO & Director)

Mr. Matthew K. Harbaugh (Exec. VP & CFO)

Mr. Dale A. Wolf (Sr. VP of Global Operations)

Products/ Services
Biotechnology, Health Care, Medical Device
Number of Employees
1,000 - 20,000
Headquarters
San Diego, California, United States
Established
1997
Company Registration
SEC CIK number: 0001142596
Net Income
2M - 5M
Revenue
Above - 1B
Traded as
NUVA
Social Media
Overview
Location
Summary
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary implant device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
History

NuVasive incorporated on July 21, 1997, as a medical device company in San Diego, California. The NuVasive approach to Minimally Invasive Surgery was a new surgical platform called Maximum Access Surgery . The flagship procedure is the XLIF procedure, a minimally disruptive procedure that allows spine surgeons to have direct access to the intervertebral space from the side of the body, as opposed to the front or back. Their patient support division is called The Better Way Back. NuVasive acquired the LessRay product from SafeRay Spine and launched the product in 2018 as a fluoroscopy system that enhances the clarity of radiographic images. They provide medical equipment, surgical support, and necessary funds to those in need of spine surgery around the world through the NuVasive Spine Foundation.

Mission
Our mission is to leverage our unique combination of proprietary technology, highly trained clinical support teams, and advanced education to bring forward superior solutions and enhance the quality of life for everyone we serve.
Vision
Our vision is to develop the most patient-friendly, least disruptive and cost- effective surgical solutions that allow surgeons to focus on their patients more efficiently.
Key Team

Mr. Nathaniel B. Sisitsky Esq. (Sr. VP, Gen. Counsel & Corp. Sec.)

Mr. Marc Rosenbaum (VP, Corp. Controller & Chief Accounting Officer)

Mr. Ryan Donahoe (Sr. VP & Chief Technology Officer)

Mr. Johnson Lai (Chief Information Officer)

Ms. Juliet C. Cunningham (VP of Investor Relations)

Mr. Michael Farrington (Sr. VP of People & Culture)

Mr. Sean Freeman (Sr. VP of Strategy & Corp. Devel.)

Recognition and Awards
NuVasive has received numerous awards for our enduring commitment to superior patient care, including being ranked #5 on FORTUNE magazine’s Best Workplaces in Medical Devices 2017 and ranked #17 among the World’s Best Workplaces on Civil Society’s 2018 Global Workplace List.
References
NuVasive
Leadership team

Mr. J. Christopher Barry (CEO & Director)

Mr. Matthew K. Harbaugh (Exec. VP & CFO)

Mr. Dale A. Wolf (Sr. VP of Global Operations)

Products/ Services
Biotechnology, Health Care, Medical Device
Number of Employees
1,000 - 20,000
Headquarters
San Diego, California, United States
Established
1997
Company Registration
SEC CIK number: 0001142596
Net Income
2M - 5M
Revenue
Above - 1B
Traded as
NUVA
Social Media